Center for Biologics Evaluation and Research

CBER is the Center within the FDA responsible for ensuring the safety and efficacy of blood and blood products, vaccines, allergenics, and biological therapeutics. CBER reviews some in vitro diagnostic products including any product related to testing of the blood supply, HLA products and HIV-related products.




Related Terms

Share / Follow



Recent Blogs

Evolution of an Assay Could this also be a revolution in FDA thinking?
Good Grief! FDA's Latest LDT Announcements Here we go again...
Looking Back on the IVD Hall of Fame Even if it's not your list, here's no denying their impact on the practice of medicine
Allomap Making a difference in the lives of heart transplant patients

Glossary Terms

Efficacy
In Vitro Diagnostic (IVD)